MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Brain volume changes in relation to intracortical inhibition and clinical benefit of pallidal stimulation in dystonia: a combined VBM and TMS study.

    R. Jech, A. Fečíková, V. Čejka, V. Čapek, D. Šťastná, F. Růžička, D. Urgošík, E. Růžička (Prague, Czech Republic)

    Objective: To explore the relationship between brain morphology, clinical effects of bilateral pallidal stimulation (GPi DBS) and intracortical inhibition of the motor cortex in patients…
  • 2017 International Congress

    Self-assessed psychological symptoms, fatigue and depersonalization in dystonia

    R. Newby, J. Alty, S. Jamieson, S. Smith, P. Kempster (Melbourne, Australia)

    Objective: To assess depressive, anxiety, fatigue and dissociative symptoms in patients with dystonia. Background: The basal ganglia, once considered exclusively concerned with motor control, are…
  • 2017 International Congress

    Focal dystonia as an early symptom of CACNA1A mutation: case report and literature review.

    Y. Gu, K. Kumar, C. Sue (Sydney, Australia)

    Objective: We describe two cases, a father-daughter pair, of CACNA1A mutation with task specific dystonia as an early feature. The father otherwise had a phenotype…
  • 2017 International Congress

    Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

    T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)

    Objective: To assess the frequency of extrapyramidal signs in patients with NS compared to patients with MS. Background: Specific inflammatory pathways and specifically Tumor necrosis…
  • 2017 International Congress

    Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study

    M. Amarandei (Bucharest, Romania)

    Objective: -the efficacy of the anti-CD20 antibody, Rituximab, in the treatment of patients with Stiff-person syndrome Background: SPS is a rare autoimmune progressive disorder of…
  • 2017 International Congress

    Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

    O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

    Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…
  • 2017 International Congress

    Study Design of an Efficacy and Safety Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of APL-130277 in the Treatment of OFF Episodes (CTH-300)

    C.W. Olanow, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro (New York, NY, USA)

    Objective: To review the unique features of the ongoing Phase 3 trial for APL-130277.  Background: Patients with Parkinson’s disease (PD) frequently develop problematic OFF episodes…
  • 2017 International Congress

    Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, A. Kühn, L. Timmermann, M. Pötter-Nerger, P. Eldridge, J. Volkmann, J. Fitzgerald, A. Schnitzler, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To investigate the effectiveness and safety-related real-world outcomes of a multiple-source, constant current Deep Brain Stimulation (DBS) System in the treatment of levodopa-responsive Parkinson’s…
  • 2017 International Congress

    Improvement on gait in Parkinson’s disease patients using Honda stride management assist device

    N. Kawashima, M. Matsuhashi, T. Hamano, K. Nagami, T. Furukado, M. Iijima, M. Isogai, M. Komachi, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the effect of a wearable exoskeleton stride management assist device (SMAD: Honda R and D Corporation, Japan) on gait in Parkinson's disease…
  • 2017 International Congress

    A prospective randomized cross-over study of telemedicine system in Parkinson’s disease

    S. Sekimoto, G. Oyama, T. Hatano, F. Sasaki, R. Nakamura, T. Jo, Y. Shimo, N. Hattori (Tokyo, Japan)

    Objective: To investigate the validity of telemedicine system in Parkinson’s disease(PD). Background: PD patients may be difficult to visit the hospitals because of decline of…
  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley